AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 101 min read$ISRG

Brosius Mark sold $29K of ISRG

Brosius Mark (EVP & Chief Mfg and Supply Cha) sold 69 shares of INTUITIVE SURGICAL INC (ISRG) at an average of $421.80 ($420.12–$424.14) across 3 trades over 2026-06-08 to 2026-06-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brosius Mark
Published Jun 10, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 10:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ISRG
Neutral
high confidence
Mentioned
$ISRG
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ISRGNeutralLow
01

Why it matters

The filing provides transparency on officer selling activity but does not introduce new business, regulatory, or financial information.

02

Market read

Useful for monitoring insider behavior, but the disclosed sale size and 10b5-1 structure suggest limited trading edge.

03

What to watch

Traders may over-weight small insider sales; the more relevant signal would be large, non-10b5-1 sales or purchases, which are not present here.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-10 (transactions dated 2026-06-08 to 2026-06-10).

Background

The article is an SEC Form 4 insider transaction filing (open-market sale) for Intuitive Surgical.

Company-level read

Ticker impact

$ISRGNeutralHigh confidence
Context

Intuitive Surgical Form 4 shows EVP Mark Brosius sold 69 shares in open-market transactions at ~$420.12–$424.14 (10b5-1 plan).

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The disclosure is a small, pre-arranged Rule 10b5-1 sale by an officer, with no accompanying operational/regulatory/financial catalyst in the text.

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide datapoint.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because it’s explicitly a pre-arranged 10b5-1 plan, the sale may be mechanically scheduled and not a bearish read-through.

Key entities

  • issuer
    Intuitive Surgical

    Company whose insider transaction is disclosed on SEC Form 4.

  • insider
    Brosius Mark

    EVP & Chief Mfg and Supply Chain officer who sold shares under a Rule 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ISRG insider trading history →

Related articles

SEP 30
$ISRGHighAI 8/10

Intuitive receives CE mark for da Vinci 5 cardiac procedures

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci 5 system in cardiac procedures, including coronary artery bypasses and thoracoscopic cardiotomy. The company aims to expand its robotic-assisted cardiac surgery offerings in Europe, with a dedicated team and partnerships with select centers. ISRG previously received FDA clearance for cardiac use in January.

massdevice.com2 min
SEP 29
$ISRGHighAI 8/10

Intuitive Surgical Gains CE Mark for Cardiac Robotics

Intuitive Surgical received CE mark approval for its da Vinci surgical robot to perform cardiac procedures in adults, including minimally invasive coronary artery bypass. This approval allows Intuitive to compete with rivals Medtronic and Johnson & Johnson in the surgical robotics space. The company aims to expand its cardiac surgery offerings globally, following FDA clearance for cardiovascular procedures in January.

mddionline.com3 min
SEP 15
$ISRGHighAI 8/10

Intuitive receives CE mark for transvaginal use of da Vinci SP system

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci SP system for transvaginal gynecological procedures in Europe, expanding its use in women's health. The system, already approved for other surgeries, allows single-incision operations, potentially improving recovery and outcomes. It is also approved in the US, Japan, and Korea.

yahoo.com2 min
SEP 14
$ISRGHigh

Intuitive announces expanded indication for da Vinci SP in Europe

Intuitive (ISRG) received CE mark approval for transvaginal gynecologic procedures using the da Vinci SP system in Europe, expanding its applications. The approval allows for less invasive options and potentially better recovery experiences. The system is already approved in the US, Japan, and Korea for various procedures.

prnewswire.com2 min